{"entity":{"type":"insider","cik":"0001712417","url":"/insider/0001712417","json_url":"/insider/0001712417.json","name":"Canaan XI L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":4,"first":"2021-06-02","last":"2022-09-22","span_basis":"filed_date"},"name_variants":[{"name":"Canaan XI L.P.","source":"filing","n_filings":4,"first_seen":"2021-06-02","last_seen":"2022-09-22"}],"transactions":[{"id":6503068,"accession":"0000899243-22-031692","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-031692","line_url":"/filing/0000899243-22-031692","is_derivative":false,"issuer_cik":"0001712417","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001712417","owner_cik":null,"owner_name":"Canaan Partners XI LLC; Canaan XI L.P.","owner_display_name":"Canaan Partners XI LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":613603.0,"shares_display":"613,603","price_per_share":18.547463294670983,"price_display":"18.55","price_state":"stated","total_value":11380779.12,"total_display":"11,380,779.12","total_whole":"11,380,779","shares_owned_after":8470407.0,"shares_owned_after_display":"8,470,407","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-22","scope":"insider","n_lines":2},{"id":6620696,"accession":"0000899243-22-031602","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-031602","line_url":"/filing/0000899243-22-031602","is_derivative":false,"issuer_cik":"0001712417","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001712417","owner_cik":null,"owner_name":"Canaan Partners XI LLC; Canaan XI L.P.","owner_display_name":"Canaan Partners XI LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":148670.0,"shares_display":"148,670","price_per_share":19.50914508643304,"price_display":"19.51","price_state":"stated","total_value":2900424.6,"total_display":"2,900,424.60","total_whole":"2,900,425","shares_owned_after":9080170.0,"shares_owned_after_display":"9,080,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-20","filed_date":"2022-09-20","scope":"insider","n_lines":2},{"id":6620689,"accession":"0000899243-22-031602","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-031602","line_url":"/filing/0000899243-22-031602#line-3","is_derivative":false,"issuer_cik":"0001712417","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001712417","owner_cik":null,"owner_name":"Canaan Partners XI LLC; Canaan XI L.P.","owner_display_name":"Canaan Partners XI LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76725.0,"shares_display":"76,725","price_per_share":20.57,"price_display":"20.57","price_state":"stated","total_value":1578233.25,"total_display":"1,578,233.25","total_whole":"1,578,233","shares_owned_after":9226574.0,"shares_owned_after_display":"9,226,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-19","filed_date":"2022-09-20","scope":"insider"},{"id":6620684,"accession":"0000899243-22-031602","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-031602","line_url":"/filing/0000899243-22-031602","is_derivative":false,"issuer_cik":"0001712417","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001712417","owner_cik":null,"owner_name":"Canaan Partners XI LLC; Canaan XI L.P.","owner_display_name":"Canaan Partners XI LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115307.0,"shares_display":"115,307","price_per_share":21.54646231364965,"price_display":"21.55","price_state":"stated","total_value":2484457.93,"total_display":"2,484,457.93","total_whole":"2,484,458","shares_owned_after":9307021.0,"shares_owned_after_display":"9,307,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-20","scope":"insider","n_lines":2},{"id":6974602,"accession":"0000899243-22-031191","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-031191","line_url":"/filing/0000899243-22-031191","is_derivative":false,"issuer_cik":"0001712417","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001712417","owner_cik":null,"owner_name":"Canaan Partners XI LLC; Canaan XI L.P.","owner_display_name":"Canaan Partners XI LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51281.0,"shares_display":"51,281","price_per_share":22.85074686531074,"price_display":"22.85","price_state":"stated","total_value":1171809.15,"total_display":"1,171,809.15","total_whole":"1,171,809","shares_owned_after":9421920.0,"shares_owned_after_display":"9,421,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-15","scope":"insider","n_lines":2},{"id":6974597,"accession":"0000899243-22-031191","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-031191","line_url":"/filing/0000899243-22-031191","is_derivative":false,"issuer_cik":"0001712417","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001712417","owner_cik":null,"owner_name":"Canaan Partners XI LLC; Canaan XI L.P.","owner_display_name":"Canaan Partners XI LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106111.0,"shares_display":"106,111","price_per_share":23.682207499693718,"price_display":"23.68","price_state":"stated","total_value":2512942.72,"total_display":"2,512,942.72","total_whole":"2,512,943","shares_owned_after":9470271.0,"shares_owned_after_display":"9,470,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-14","filed_date":"2022-09-15","scope":"insider","n_lines":2},{"id":6974589,"accession":"0000899243-22-031191","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-031191","line_url":"/filing/0000899243-22-031191","is_derivative":false,"issuer_cik":"0001712417","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001712417","owner_cik":null,"owner_name":"Canaan Partners XI LLC; Canaan XI L.P.","owner_display_name":"Canaan Partners XI LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87647.0,"shares_display":"87,647","price_per_share":24.397095051741644,"price_display":"24.40","price_state":"stated","total_value":2138332.19,"total_display":"2,138,332.19","total_whole":"2,138,332","shares_owned_after":9577001.0,"shares_owned_after_display":"9,577,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-13","filed_date":"2022-09-15","scope":"insider","n_lines":2},{"id":5392198,"accession":"0000899243-21-021571","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-021571","line_url":"/filing/0000899243-21-021571#line-3","is_derivative":false,"issuer_cik":"0001712417","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001712417","owner_cik":null,"owner_name":"Canaan Partners XI LLC; Canaan XI L.P.","owner_display_name":"Canaan Partners XI LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13000.0,"shares_display":"13,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":208000.0,"total_display":"208,000.00","total_whole":"208,000","shares_owned_after":10735645.0,"shares_owned_after_display":"10,735,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001845337","name":"Day One Biopharmaceuticals, Inc.","url":"/issuer/0001845337","role":"Ten percent owner","n_filings":4,"first_seen":"2021-06-02","last_seen":"2022-09-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001712417","retrieved_at":"2026-08-23T17:42:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}